Following Baby Back Home (FBBH)
Last updated: 2020
Evidence of model effectiveness
This model does not meet the criteria established by the Department of Health and Human Services (HHS) for an “evidence-based early childhood home visiting service delivery model” for the general population or for tribal populations because there are no high- or moderate-rated effectiveness studies of the model.
Following Baby Back Home (FBBH) serves families residing in Arkansas with medically complex, high-risk infants discharged from the neonatal intensive care unit (NICU). FBBH aims to reduce morbidity and mortality rates among medically complex, high-risk infants by reducing preventable infant rehospitalizations, improving adherence to infant medical appointments and immunizations, and increasing families’ skills and self-efficacy in caring for their high-risk infants. The model consists of home visits with a registered nurse and a licensed social worker. The home visiting team provides care coordination, helps families identify local resources to meet the infant’s service needs, and provides referrals to support families’ social functioning and overall well-being. FBBH offers services immediately following the infant’s discharge from the NICU until the child's third birthday. FBBH includes two home visits per month for the first two months after enrollment, one home visit per month until the child is one year old, and one visit every other month until the child's third birthday. For more information, please read the Model Overview.
Extent of evidence
Criteria established by the U.S. Department of Health and Human Services
Notes: If the model does not meet criterion 3 but meets criteria 1 and 2 based on findings from subgroups, the impacts must be replicated in the same domain in two or more studies using non-overlapping analytic study samples. HomVEE assesses and reports criteria 4 and 5 for all models that have well-designed research, but meeting those two criteria is only required of models for which all findings are from randomized controlled trials. Please read the HHS criteria for evidence-based models for more information.